Drugs in Context, Год журнала: 2024, Номер 13, С. 1 - 19

Опубликована: Июль 2, 2024

Abnormal uterine bleeding (AUB) is an acute/chronic variation in the normal menstrual cycle that affects adolescents, women of reproductive age and perimenopausal women. AUB approximately 3-30% reproductive-aged worldwide, reduces their quality life productivity whilst increasing overall healthcare burden. Its management requires thorough medical evaluation individualized treatment. Depending on severity cause AUB, its treatment ranges from lifestyle modifications hormonal therapies to more invasive procedures or surgery. Although therapy preferred first-line measure available pharmacological options have various adverse effects. There exists a need for safer efficient regimens with high patient compliance effectively treat AUB. Norethisterone, also known as norethindrone, widely used synthetic analogue progestogen. Controlled release formulations norethisterone/ norethisterone acetate help maintain constant drug levels blood exert minimal side-effects; therefore, they are promising therapeutic agents effective management. The present review summarizes epidemiology diagnosis focus safety, efficacy tolerability We report case 40-year-old woman, who was treated NETA tablets. resulted favourable outcomes, satisfaction.

Язык: Английский